Gyeonggi-do, South Korea

Man Sil Park


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Man Sil Park: Innovator Behind Breakthrough in Thyrotropin Receptor Therapy**

Introduction

Man Sil Park, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions in the field of biotechnology. With a focus on developing innovative therapeutic solutions, Park's work has gained attention due to its potential to improve treatments for Graves' disease and related conditions.

Latest Patents

Park holds a notable patent titled "Fusion protein comprising thyrotropin receptor variants and use thereof." This invention entails a fusion protein that features a thyrotropin receptor (TSHR) fragment, specifically an extracellular domain of a wild-type TSHR, which includes an amino acid substitution at a designated position, combined with an immunoglobulin Fc region or a carboxy-terminal cap (C-CAP). The fusion protein exhibits enhanced pharmaceutical efficacy, in-vivo persistence, and improved stability. Furthermore, the pharmaceutical composition containing this fusion protein serves as an active ingredient, offering valuable therapeutic and diagnostic applications for alleviating Graves' disease and Graves' ophthalmopathy.

Career Highlights

Throughout his career, Man Sil Park has collaborated with prominent organizations such as Yuhan Corporation and the Industry-Academic Cooperation Foundation at Yonsei University. His positions at these institutions have allowed him to leverage advanced research methods, contributing to innovative healthcare solutions.

Collaborations

During his professional journey, Park has worked alongside talented colleagues, including Moo Young Song and Taejin Yoon. Their teamwork has been instrumental in driving forward Park's innovative research and development efforts in biomedical applications, particularly concerning thyroid disorders.

Conclusion

Man Sil Park stands out as a significant figure in the realm of biotechnology, with his contributions poised to impact the treatment landscape for thyroid-related diseases. His work on fusion protein technologies reflects a commitment to advancing medical science and improving patient outcomes through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…